<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND &amp; OBJECTIVES: <z:hpo ids='HP_0002863'>Myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) is a clonal haematopoietic stem cell disorder characterized by ineffective haematopoiesis and <z:mpath ids='MPATH_336'>leukaemia</z:mpath> progression </plain></SENT>
<SENT sid="1" pm="."><plain>Cytogenetic analysis has proven to be a mandatory part of the diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> as well as a major indicator for predicting clinical course and outcome </plain></SENT>
<SENT sid="2" pm="."><plain>Studies on cytogenetics of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> are reported mostly from the West and only a few are available from Asian countries </plain></SENT>
<SENT sid="3" pm="."><plain>We report herein cytogenetic studies on 40 Indian patients with primary <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> to find out the occurrence and type of chromosome abnormalities and recurring defects </plain></SENT>
<SENT sid="4" pm="."><plain>METHODS: Cytogenetic analysis was done using GTG banding and karyotyped according to the International System for Human Cytogenetic Nomenclature (ISCN) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Of the 40 patients, 19 patients (47.5%) showed clonal karyotypic abnormalities with distribution as follows: 3 of 15 (20%) of refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> (RA), 4 of 7 (57%) of refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with excess blasts-1 (<z:e sem="disease" ids="C1318550" disease_type="Neoplastic Process" abbrv="">RAEB-1</z:e>), 4 of 6 (67%) of refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with excess blasts 2 (<z:e sem="disease" ids="C1318551" disease_type="Neoplastic Process" abbrv="">RAEB-2</z:e>), 2 of 3 (67%) of refractory <z:hpo ids='HP_0001903'>anaemia</z:hpo> with ring sideroblasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RARS</z:e>), 2 of 4 (50%) of refractory cytopenia with multilineage <z:mpath ids='MPATH_589'>dysplasia</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RCMD</z:e>), none (0%) <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RCMD</z:e>-ringed sideroblasts (<z:e sem="disease" ids="C1301356" disease_type="Neoplastic Process" abbrv="">RCMD-RS</z:e>) and 4 patients with <z:e sem="disease" ids="C0740302" disease_type="Disease or Syndrome" abbrv="">5q syndrome</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>The frequent abnormalities observed in our study were -7, 5q-and <z:mp ids='MP_0004027'>trisomy</z:mp> 8 </plain></SENT>
<SENT sid="7" pm="."><plain>INTERPRETATION &amp; CONCLUSIONS: Two rare chromosomal abnormalities (6q-, 3q-) were found with unknown prognostic significance </plain></SENT>
<SENT sid="8" pm="."><plain>Hence, cytogenetic analysis may be incorporated in the routine diagnosis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> since there are racial differences in clinical pictures and the molecular events </plain></SENT>
</text></document>